As we await the 2022-23 Final Budget Outcome, an analysis of forecast government spending on the pharmaceuticals sub-function reveals a potentially significant spike in topline growth. It also shows how Budget estimates for low or no growth can be very misleading because of what they do not include. …
Final Budget Outcome will confirm the extent of topline PBS growth
September 18, 2023 Latest NewsBioPharma'The Facts'
Latest Video
New Stories
-
This exchange on the HTA Review was about as underwhelming as it sounds
October 9, 2025 - - Latest News -
AusBiotech unveils international conference program for Australia’s biggest week in biotech
October 9, 2025 - - Australian Biotech -
Life sciences industry calls for stronger national strategy to support trials and innovation
October 9, 2025 - - Latest News -
Officials outline ongoing measures to address ADHD medicine shortages
October 9, 2025 - - Latest News -
Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs
October 9, 2025 - - Latest News -
Australian company reports positive outcome from collaboration
October 8, 2025 - - Australian Biotech -
CUREator opens $33 million funding round with CSL and AbbVie partnership
October 8, 2025 - - Latest News